Search results
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Comfort...
Benzinga· 12 hours agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 6 days agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH ā...
VTYX DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc....
The Sun Chronicle· 5 days agoNEW YORK, April 29, 2024 /PRNewswire/ --
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 6 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 2 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
722 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by McAdam LLC
ETF DAILY NEWS· 2 days agoMcAdam LLC purchased a new position in Amgen Inc. (NASDAQ:AMGN ā Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
How a Florida man overcame a broken femur, fractured pelvis and now heart disease
Tampa Bay Times· 2 days agoLast month, 50 years of bike riding, running and pretending Iām Arnold Schwarzenegger in the gym failed me. With three grandparents dying of heart disease, I knew all along I was doomed. Late ...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks· 1 day agoFree Report) reported a loss of 69 cents per share in the first quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 73 cents. In the year-ago quarter, Kymera reported a ...
Amgen (AMGN) Scheduled to Post Earnings on Thursday
ETF DAILY NEWS· 4 days agoAmgen (NASDAQ:AMGN ā Get Free Report) is set to announce its earnings results after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of $3.82 per share ...
PhRMA to Revive Medicare Drug Price Lawsuit Before Fifth Circuit
Bloomberg Law· 4 days agoA health provider trade association, a patient advocacy group, and a top drug lobby will attempt to restore their case against a government drug price-setting program before a federal appeals ...